REFERENCES
- Athale U, Siciliano S, Thabane L, Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer. Pediatr Blood Cancer. 2008;51:792–797.
- Caruso V, Iacoviello L, Di Castelnuovo A, Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216–2222.
- Payne JH, Vora AJ. Thrombosis and acute lymphoblastic leukaemia. Br J Haematol. 2007;138:430–445.
- Mitchell L, Lambers M, Flege S, Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood. 2010;115:4999–5004.
- Pui CH, Campana D, Pei D, Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730–2741.
- Giordano P, Del Vecchio GC, Santoro N, Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups. Pediatr Hematol Oncol. 2000;17:667–672.
- Giordano P, Santoro N, Del Vecchio GC, T-immunophenotype is associated with an increased prevalence of thrombosis in children with acute lymphoblastic leukemia. A retrospective study. Haematologica. 2003;88:1079–1080.
- Athale UH, Siciliano SA, Crowther M, Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease. Br J Haematol. 2005;129:803–810.
- Nowak-Gottl U, Ahlke E, Fleischhack G, Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood. 2003;101:2529–2533.
- Yang L, Panetta JC, Cai X, Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol. 2008;26:1932–1939.
- Appel IM, Hop WC, van Kessel-Bakvis C, L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia. Thromb Haemost. 2008;100:330–337.
- Boos J, Werber G, Ahlke E, Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. Eur J Cancer. 1996;32A:1544–1550.
- Mitchell LG, Andrew M, Hanna K, A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with l-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer. 2003;97:508–516.
- Almawi WY, Finan RR, Tamim H, Differences in the frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene among the Lebanese population. Am J Hematol. 2004;76:85–87.
- Di Minno MN, Tremoli E, Coppola A, Homocysteine and arterial thrombosis: challenge and opportunity. Thromb Haemost. 2010;103:942–961.